MedPath

BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

India's Corbevax COVID-19 Vaccine Upgraded from Emergency Use to Full Drug Approval for Ages 5 and Above

India's Subject Expert Committee has recommended upgrading Biological E's Corbevax COVID-19 vaccine from emergency use authorization to full drug approval for individuals aged 5 years and above after reviewing extensive safety and efficacy data.

India Launches First Indigenous HPV Test Kits for Cervical Cancer Screening

Indigenously developed HPV test kits for cervical cancer screening were launched in Delhi, targeting the seven to eight most common cancer-causing HPV types specific to India's population.

© Copyright 2025. All Rights Reserved by MedPath